FDA Import Refusal 799-3200339-4/11/1 — Aurobindo Pharma Ltd
The FDA refused shipment 799-3200339-4/11/1 from Aurobindo Pharma Ltd (India) on June 29, 2021. The refused product falls under Drugs and Biologics — EMTRICITABINE; TENOFOVIR DISOPROXIL FUMERATE (ANTI-VIRAL). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- June 29, 2021
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62VDY77 EMTRICITABINE; TENOFOVIR DISOPROXIL FUMERATE (ANTI-VIRAL)
- Charges
- 75